ArticleDie Ophthalmologie2025
[DMEK for endothelial decompensation after penetrating keratoplasty].
Article in Die Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn recent years, the Descemet membrane endothelial keratoplasty (DMEK) has become the standard transplantation procedure for endothelial corneal diseases due to faster visual recovery and lower graft rejection rates compared to penetrating keratoplasty (pKPL). Endothelial corneal decompensation after pKPL is also a possible indication for DMEK. The question is which intraoperative and postoperative aspects need to be considered.
methodsWe retrospectively reviewed the DMEK surgeries performed in our clinic in 2020 and 2021 after pKPL (n = 10) regarding intraoperative and postoperative characteristics as well as functional and morphological results.
resultsOf the 10 eyes analyzed a repeat pKPL could be avoided by DMEK in 7 cases. The initial situation of the eyes was very different with respect to corneal decompensation, the primary indications for pKPL and number of previous pKPLs. The rate of postoperative gas re-injections (re-bubblings) was 80%, in some cases requiring multiple gas injections. A 20% sulphur hexafluoride (SF6) gas-air mixture was used for gas endotamponade. The improvement in visual acuity was highly variable. Overall, visual acuity in the treated eyes increased by 5.1 ± 1.4 lines after DMEK in the pKPL eyes (p < 0.001, minimum 3 lines, maximum 7 lines; logMAR preoperative 1.48 ± 0.36 to logMAR postoperative 0.57 ± 0.28).
conclusionThe use of DMEK for endothelial graft failure after pKPL is a possible minimally invasive procedure to avoid repeat pKPL. The postoperative follow-up requires significantly more re-bubblings due to the altered anatomical situation and geometry of the posterior corneal surface after pKPL and the resulting poorer adhesion of Descemet's lamella.
Indexed as
Identifiers
40879748What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.